|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Patento numeris | 3585437 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18707340.8 |
| Europos patento paraiškos padavimo data | 2018-02-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/054376 |
| Data | 2018-02-22 |
| (87) | Numeris | WO 2018/153980 |
| Data | 2018-08-30 |
| (30) | Numeris | Data | Šalis |
| 17157835 | 2017-02-24 | EP |
| (72) |
NINGSHU, Liu , DE
|
| (73) |
Bayer Pharma Aktiengesellschaft ,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY |
| COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY |